These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 866798

  • 21. Treatment of advanced carcinoma of the prostate with estramustine phosphate.
    Nagel R, Köllin CP.
    Br J Urol; 1977 Feb; 49(1):73-9. PubMed ID: 837052
    [Abstract] [Full Text] [Related]

  • 22. [Estracyt treatment in prostatic neoplasms].
    Sander S.
    Tidsskr Nor Laegeforen; 1976 Jan 10; 96(1):27-8. PubMed ID: 1257949
    [No Abstract] [Full Text] [Related]

  • 23. Estramustine phosphate in prostate cancer. EORTC experience: preliminary results of Protocol 30762.
    Smith PH, Robinson M, Richards B, Suciu S, De Pauw M, Sylvester R, Denis L.
    Urology; 1984 Jun 10; 23(6 Suppl):64-8. PubMed ID: 6375083
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Treatment of advanced carcinoma of the prostate with estramustine phosphate (estracyt)].
    Lancina Martín JA, Chantada Abal V, Lamas Meilan AC, González Martín M.
    Actas Urol Esp; 1984 Jun 10; 8(5):399-402. PubMed ID: 6524487
    [No Abstract] [Full Text] [Related]

  • 27. Primary treatment of prostatic carcinoma with estramustine phosphate: preliminary report.
    Nilsson T, Jonsson G.
    J Urol; 1976 Feb 10; 115(2):168-9. PubMed ID: 1249870
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Prostatic cancer. Transcortin levels during treatment with estramustine phosphate.
    Sandberg AA, Rosenthal H, Mittelman A, Murphy GP.
    Urology; 1975 Jul 10; 6(1):17-21. PubMed ID: 1145919
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Estramustine phosphate therapy in poorly differentiated carcinoma of the prostate.
    Edsmyr F, Esposti PL, Andersson L.
    Scand J Urol Nephrol Suppl; 1980 Jul 10; 55():139-42. PubMed ID: 6938017
    [Abstract] [Full Text] [Related]

  • 33. Combined therapy of advanced prostatic carcinoma with estramustine and prednimustine.
    Catane R, Kaufman J, Mittelman A, Murphy GP.
    J Urol; 1977 Mar 10; 117(3):332-5. PubMed ID: 839597
    [Abstract] [Full Text] [Related]

  • 34. Estramustine phosphate (Estracyt) treatment of T3-T4 prostatic carcinoma.
    Veronesi A, Zattoni F, Frustaci S, Galligioni E, Tirelli U, Trovó G, Tumolo S, Merlo A, Artuso G, Cosciani-Cunico S, Grigoletto E.
    Prostate; 1982 Mar 10; 3(2):159-64. PubMed ID: 7088731
    [Abstract] [Full Text] [Related]

  • 35. Estramustine phosphate (Estracyt) in the treatment of prostatic carcinoma.
    Könyves I.
    Int Urol Nephrol; 1989 Mar 10; 21(4):393-7. PubMed ID: 2693392
    [Abstract] [Full Text] [Related]

  • 36. Estracyt--clinical experiences.
    Nilsson T.
    Scand J Urol Nephrol Suppl; 1980 Mar 10; 55():135-8. PubMed ID: 6938016
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Estramustine phosphate in secondary hormone-resistant carcinoma of the prostate.
    Maier U, Hienert G, Simak R.
    Eur Urol; 1990 Mar 10; 17(3):216-8. PubMed ID: 2351191
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.